Related Experiment Videos
Pheochromocytoma: a frequent indicator for MEN 2
C Calmettes1, M Rosenberg-Gourgin, J Caron
1CHU St. Antoine, Paris, France.
Henry Ford Hospital Medical Journal
|January 1, 1992
Summary
Pheochromocytoma is a common initial sign of Multiple Endocrine Neoplasia type 2A (MEN 2A). Early detection of pheochromocytoma prompts essential screening for medullary thyroid carcinoma and family genetic testing.
Area of Science:
- Endocrinology
- Oncology
- Genetics
Background:
- Pheochromocytoma is a recognized clinical manifestation of Multiple Endocrine Neoplasia type 2A (MEN 2A).
- Understanding the initial presentation of MEN 2A is crucial for timely diagnosis and management.
Purpose of the Study:
- To evaluate the frequency and significance of pheochromocytoma as the first clinical manifestation in French families with MEN 2A.
- To emphasize the diagnostic implications of pheochromocytoma in the context of MEN 2A.
Main Methods:
- Retrospective analysis of 35 French MEN 2A families.
- Identification of patients where pheochromocytoma was the initial presenting symptom.
Main Results:
- In 30% of MEN 2A patients within these families, pheochromocytoma was the first sign.
- Pheochromocytoma represented 45% of all initial manifestations in patients diagnosed with MEN 2A.
Conclusions:
- Pheochromocytoma serves as a critical early indicator for Multiple Endocrine Neoplasia type 2A.
- Diagnosis of pheochromocytoma necessitates further investigation for medullary thyroid carcinoma and family screening.